UNITED STATES FOOD AND DRUG ADMINISTRATION AND PHARMACEUTICAL INDUSTRY

被引：2

|

作者：

GARLAND, J

机构：

来源：

BRITISH MEDICAL JOURNAL | 1961年 / 1卷 / 523期

关键词：

D O I：

10.1136/bmj.1.5237.1452

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1452 / &

相关论文

共 50 条

[21] United States Food and Drug Administration and Department of Defense Shelf-Life Extension Program of Pharmaceutical Products: Progress and Promise
Khan, Saeed R.
Kona, Ravikanth
Faustino, Patrick J.
Gupta, Abhay
Taylor, Jeb S.
Porter, Donna A.
Khan, Mansoor
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (05) : 1331 - 1336
[22] HOW THE PHARMACEUTICAL-INDUSTRY BRINGS AN ANTIBIOTIC DRUG TO MARKET IN THE UNITED-STATES
BILLSTEIN, SA
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) : 2679 - 2682
[23] MONITORING ADVERSE REACTIONS TO FOOD-ADDITIVES IN THE UNITED-STATES-FOOD-AND-DRUG-ADMINISTRATION
TOLLEFSON, L
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) : 438 - 446
[24] FOOD INGREDIENT SAFETY EVALUATION - GUIDELINES FROM THE UNITED-STATES-FOOD-AND-DRUG-ADMINISTRATION
PAULI, GH
ACS SYMPOSIUM SERIES, 1992, 484 : 140 - 148
[25] FEDERAL FOOD AND DRUG ADMINISTRATION IN UNITED-STATES - BORN AND BRED IN CRISES
TAYLOR, WJR
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1973, 7 (2-3) : 156 - 162
[26] End points and United States food and drug administration approval of oncology drugs
Johnson, JR
Williams, G
Pazdur, R
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1404 - 1411
[27] Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration
Nguyen, Christopher N.
Nguyen, Quoc-Bao D.
Silapunt, Sirunya
PHLEBOLOGY, 2022, 37 (06) : 452 - 459
[28] What's new on nutrition labeling at the United States Food and Drug Administration?
Brandt, MB
LeGault, LA
JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2003, 16 (03) : 383 - 393
[29] United States Food and Drug Administration signals crackdown on caffeinated alcohol drinks
Benac, Nancy
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (01) : E47 - E48
[30] Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration
Nguyen, Christopher
Quoc-Bao Nguyen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB17 - AB17

← 1 2 3 4 5 →